Project description
Exploiting cell endogenous degradation approaches to treat mitochondrial diseases
Mitochondria are key cellular organelles responsible for energy production. Mitochondria dysfunction can be detrimental to cell viability and lead to neuromuscular disorders known as mitochondrial myopathies. The EU-funded MTPHAGYTREAT project is working on a novel approach to treat mitochondria dysfunction by inducing mitochondria degradation through the natural mechanism of removing unwanted or damaged organelles known as autophagy. To investigate this approach, researchers will develop a mouse model that recapitulates the genetic defects of human disease. This model can also serve as a platform for testing various natural compounds for the treatment of mitochondrial diseases.
Objective
Mutations in COX15 are associated to cytochrome c oxidase (COX) deficiency (OMIM: 220110), a mitochondrial disease characterized by inefficient energy production due to the accumulation of impaired mitochondria. The phenotype of a muscle-specific Cox15 knockout (Cox15sm/sm), a model of severe mitochondrial myopathy characterized by profound COX deficiency, was previously shown to be ameliorated by the coordinated induction of autophagy and lysosomal biogenesis via TFEB activation. Stimulation of mitophagy, a selective degradation of mitochondria by autophagy, is one attractive possibility to induce the elimination of damaged mitochondria and be used as a broad-spectrum treatment for mitochondrial dysfunctions. However, the role of mitophagy in this mitochondrial dysfunction was not investigated in detail. To clarify the role of mitophagy in the amelioration of Cox15sm/sm mice phenotype and explore its therapeutic potential, a Cox15sm/sm mito-QC reporter mouse has been created in the host laboratory. Mito-QC, a pH-sensitive mitochondrial targeted probe, will allow to assess unambiguously mitophagy at single cell resolution by the quantification of the number of mitolysosomes in COX-deficient myocytes. Likewise, the investigation of the mitophagy role in muscle regeneration in the Cox15sm/sm mice can have a high impact in mitochondrial diseases. MTPHAGYTREAT will thus create a new myoblast model for the evaluation of autophagy/mitophagy role in muscle regeneration. In addition, we will take advantage of Cox15sm/sm myoblasts and advanced imaging techniques to fast track the discovery of new drugs for the treatment of mitochondrial diseases by screening a library of natural compounds previously shown to be safe for humans, thus facilitating the eventual translation to the patients.
                                Fields of science (EuroSciVoc)
                                                                                                            
                                            
                                            
                                                CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See:   The European Science Vocabulary.
                                                
                                            
                                        
                                                                                                
                            CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences basic medicine pharmacology and pharmacy drug discovery
- natural sciences biological sciences cell biology
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
                                Keywords
                                
                                    
                                    
                                        Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
                                        
                                    
                                
                            
                            
                        Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
            Programme(s)
            
              
              
                Multi-annual funding programmes that define the EU’s priorities for research and innovation.
                
              
            
          
                      Multi-annual funding programmes that define the EU’s priorities for research and innovation.
- 
                  H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions
                                      MAIN PROGRAMME
                                    
 See all projects funded under this programme
- 
                  H2020-EU.1.3.2. - Nurturing excellence by means of cross-border and cross-sector mobility
                                    
 See all projects funded under this programme
            Topic(s)
            
              
              
                Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
                
              
            
          
                      
                  Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
            Funding Scheme
            
              
              
                Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
                
              
            
          
                      Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
MSCA-IF - Marie Skłodowska-Curie Individual Fellowships (IF)
See all projects funded under this funding scheme
              Call for proposal
                
                  
                  
                    Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
                    
                  
                
            
                          Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-MSCA-IF-2020
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
35122 PADOVA
Italy
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.
 
           
        